Download
1 / 1
10 likes | 23 Views
CJC-1295 DAC is a synthetic analogue of growth hormone-releasing hormone (GHRH) (also known as growth hormone-releasing factor (GRF)) and a growth hormone secretagogue (GHS). It is a modified form of GHRH (1-29) with improved pharmacokinetics, especially in regard to half-life. CJC-1295 markedly increases plasma growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels in both animals and humans. With a single injection, in human subjects, CJC-1295 increases plasma GH levels by 2- to 10-fold for 6 days or longer and plasma IGF-1 levels by 1.5- to 3-fold for 9 to 11 days. The drug has an estimated half-life of about 6 to 8 days in humans. With multiple doses of CJC-1295, IGF-1 levels were found to remain elevated in humans for up to 28 days. CJC-1295 has been shown to extend the half-life and bioavailability of growth-hormone-releasing hormone 1-29 and stimulate insulin-like growth factor 1 secretion. It increases the half-life of acting agents by bioconjugation.
E N D
FREE SHIPPING ON ALL UK ORDERS OVER £50 HOME ALL PEPTIDES GHRH PEPTIDES GHRP PEPTIDES OTHER PEPTIDES CONTACT Search for your peptide 98%PURE PEPTIDES FOR CLINICAL cookies to RE We use NOT FOR HUMAN USE improve user experience, VIEW ALL PEPTIDES and analyze website traffic. For these NEW CUSTOMERS 20% OFF YOUR FIRST ORDER reasons, we may share your site usage data with our analytics partners. By clicking Enter your e-mail address “Accept PREFERENCES DECLINE ACCEPT Cookies,” you LATEST RESEARCH CHEMICALS consent to NO, THANKS store on your YES PLEASE! device all the technologies described in OUT OF STOCK OUT OF STOCK our Cookie Policy. You can change your cookie settings at any time by clicking “Cookie Preferences.”
